Hypoxia preconditioning targets and downregulates miR-195 and promotes bone marrow mesenchymal stem cell survival and pro-angiogenic potential by activating MALAT1

doi:10.12307/2022.136

Abstract

Abstract: BACKGROUND: Previous studies demonstrated that hypoxia preconditioning promotes bone marrow mesenchymal stem cell survival and angiogenesis. However, specific mechanism remained unclear. Both RNA-MALAT1 (MALAT1) and microRNA-195 (miR-195) are associated with bone marrow mesenchymal stem cell survival and angiogenesis. MALAT1 promotes bone marrow mesenchymal stem cell survival and angiogenesis, whereas miR-195 is a negative regulator of bone marrow mesenchymal stem cell survival and angiogenesis.
OBJECTIVE: To investigate whether hypoxia preconditioning could activate MALAT1 to target and downregulate miR-195 to further promote bone marrow mesenchymal stem cell survival and pro-angiogenic potential in vitro.
METHODS: Bone marrow mesenchymal stem cells cultured in vitro were divided into six groups: normoxia (20% O2), hypoxia preconditioning (1% O2), hypoxia preconditioning+si-MALAT1, hypoxia preconditioning+si-MALAT1 negative control, hypoxia preconditioning+miR-195 and hypoxia preconditioning+miR-195 negative control. MALAT1 siRNA and relevant scramble were transfected into the hypoxia preconditioning+si-MALAT1 and hypoxia preconditioning+si-MALAT1 negative control groups respectively prior to hypoxia preconditioning, and miR-195 mimics and relevant negative control were transfected into the hypoxia preconditioning+miR-195 and hypoxia preconditioning+miR-195 negative control groups respectively prior to hypoxia preconditioning. Mesenchymal stem cells in different groups were cultured for 24 hours and cell proliferation, apoptosis and vascularization were evaluated. The expression levels of MALAT1 and miR-195 were detected using qRT-PCR. The potential complementary binding sites of MALAT1 and miR-195 were predicted by RegRNA 2.0. miR-195 mimics and miR-195 mimics negative control were co-transfected into 293T cells with the luciferase reporters containing MALAT1 or MALAT1-mut. Luciferase activity was detected in different groups of cells in order to verify the relationship between MALAT1 and miR-195.
RESULTS AND CONCLUSION: (1) Compared with the normoxia group, the hypoxia group presented more rapid growth; cells apoptosis percentage was significantly declined; and number of vascular lumen like structures increased (P < 0.01). The expression of MALAT1 was upregulated, while the level of miR-195 was significantly decreased in the hypoxia group (P < 0.01). (2) Compared with the hypoxia preconditioning and hypoxia preconditioning+si-MALAT1 negative control groups, hypoxia preconditioning+si-MALAT1 group presented much lower growth rate, and cells apoptosis percentage was significantly higher; number of vascular lumen like structures decreased (P < 0.01). The expression of MALAT1 was decreased, while the level of miR-195 was increased (P < 0.01). Compared with the hypoxia preconditioning and hypoxia preconditioning+miR-195 negative control groups, hypoxia preconditioning+miR-195 group also presented much lower growth rate, and cells apoptosis percentage was significantly higher; number of vascular lumen like structures decreased (P < 0.01). The expression of MALAT1 was decreased, while the level of miR-195 was increased (P < 0.01). (3) The dual luciferase reporter assay indicated that compared with miR-195 control and blank control groups, the MALAT1 reporter gene luciferase activity was decreased significantly in miR-195 mimics group, down-regulating about 63% (P < 0.01). However, miR-195 mimics, miR-195 mimics negative control and blank control showed no effect on MALAT1-mut reporter gene (P > 0.05). (4) Hypoxia preconditioning could activate MALAT1 to target and downregulate miR-195 to further promote bone marrow mesenchymal stem cell survival and pro-angiogenic potential.

Key words: stem cells, bone marrow mesenchymal stem cells, hypoxia, preconditioning, angiogenesis, miR-195

CLC Number:

Hou Jingying, Guo Tianzhu, Yu Menglei, Long Huibao, Wu Hao. Hypoxia preconditioning targets and downregulates miR-195 and promotes bone marrow mesenchymal stem cell survival and pro-angiogenic potential by activating MALAT1 [J]. Chinese Journal of Tissue Engineering Research, 2022, 26(7): 1005-1011.

Figures/Tables 5

References

[1] ZHU LP, TIAN T, WANG JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018; 8(22):6163-6177.
[2] LIU Y, YANG X, MAUREIRA P, et al. Permanently hypoxic cell culture yields rat bone marrow mesenchymal cells with higher therapeutic potential in the treatment of chronic myocardial infarction. Cell Physiol Biochem. 2017;44(3):1064-1077.
[3] MENG SS, XU XP, CHANG W, et al. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning. Stem Cell Res Ther. 2018;9(1):280.
[4] FÁbián Z. The effects of hypoxia on the immune-modulatory properties of bone marrow-derived mesenchymal stromal cells. Stem Cells Int. 2019; 2019:2509606.
[5] SELVASANDRAN K, MAKHOUL G, JAISWAL PK, et al. A tumor necrosis factor-α and hypoxia-induced secretome therapy for myocardial repair.Ann Thorac Surg. 2018;105(3):715-723.
[6] CUI P, ZHAO X, LIU J, et al. miR-146a interacting with lncRNA EPB41L4A-AS1 and lncRNA SNHG7 inhibits proliferation of bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2020;235(4):3292-3308.
[7] 侯婧瑛,汪蕾,龙会宝,等.长链非编码RNA-H19 对缺血缺氧条件下骨髓间充质干细胞生存和血管再生能力的影响[J]. 中国组织工程研究,2018,22(13):1969-1975.
[8] HUANG P, WANG L, LI Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353-367.
[9] LIU D, MIAO H, REN J, et al. Long non-coding RNA MALAT1 promotes proliferation, angiogenesis, and immunosuppressive properties of mesenchymal stem cells by inducing VEGF and IDO. J Cell Biochem. 2017;118(9):2780-2791.
[10] REN L, WEI C, LI K, et al. LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting miR-145. Biosci Rep. 2019;39(3):BSR20180226.
[11] TANG L, LU W, HUANG J, et al. miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1. Mol Med Rep. 2019;20(1):270-280.
[12] HONG Y, HE H, JIANG G, et al. miR-155-5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction. Aging Cell. 2020;19(4):e13128.
[13] OKADA M, KIM HW, MATSU-URA K, et al. Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase. Stem Cells. 2016;34(1):148-159.
[14] ZHAO WJ, ZHANG HF, SU JY. Downregulation of microRNA-195 promotes angiogenesis induced by cerebral infarction via targeting VEGFA. Mol Med Rep. 2017;16(4):5434-5440.
[15] HONG S, HU S, KANG Z, et al. Identification of functional lncRNAs based on competing endogenous RNA network in osteoblast differentiation. J Cell Physiol. 2020;235(3):2232-2244.
[16] YI J, LIU D, XIAO J. LncRNA MALAT1 sponges miR-30 to promote osteoblast differentiation of adipose-derived mesenchymal stem cells by promotion of Runx2 expression. Cell Tissue Res. 2019;376(1): 113-121.
[17] YANG X, YANG J, LEI P, et al. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging (Albany NY). 2019;11(20):8777-8791.
[18] STONE JK, KIM JH, VUKADIN L, et al. Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells. J Biol Chem. 2019;294(29):11213-11224.
[19] LIU H, ZHANG Z, XIONG W, et al. Long non-coding RNA MALAT1 mediates hypoxia-induced pro-survival autophagy of endometrial stromal cells in endometriosis. J Cell Mol Med. 2019;23(1):439-452.
[20] LIU H, SHI C, DENG Y. MALAT1 affects hypoxia-induced vascular endothelial cell injury and autophagy by regulating miR-19b-3p/HIF-1α axis. Mol Cell Biochem. 2020;466(1-2):25-34.
[21] 侯婧瑛,汪蕾,钟婷婷,等. apelin干预骨髓间充质干细胞在缺血缺氧条件下的生存和血管再生[J].中国组织工程研究,2017,21(1): 6-12.
[22] HOU J, ZHONG T, GUO T, et al. Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor. Exp Mol Pathol. 2017;102(2):203-209.
[23] HOU J, WANG L, WU Q, et al. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther. 2018;9(1):109.
[24] 侯婧瑛,凌辉,金小岩,等. lncRNA-MALAT1通过靶向下调miR-570-3p促进胃癌细胞增殖[J].中国病理生理杂志,2018,34(12):2145-2152.
[25] 侯婧瑛,周长青,郑韶欣,等.用双萤光素酶报告基因技术验证小鼠lncRNA-H19与miR-199a-5p的靶向关系[J].中国病理生理杂志, 2016,32(12):2256-2260.
[26] PEZZI A, AMORIN B, LAUREANO Á, et al. Effects Of Hypoxia in Long-Term In Vitro Expansion of Human Bone Marrow Derived Mesenchymal Stem Cells. J Cell Biochem. 2017;118(10):3072-3079.
[27] HU Y, CHEN W, WU L, et al. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction. Cell Biochem Funct. 2019;37(7):504-515.
[28] JAÉ N, HEUMÜLLER AW, FOUANI Y, et al. Long non-coding RNAs in vascular biology and disease. Vascul Pharmacol. 2019;114:13-22.
[29] SUN Z, OU C, LIU J, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2019;38(14):2627-2644.
[30] YU B, GONG M, HE Z, et al. Enhanced mesenchymal stem cell survival induced by GATA-4 overexpression is partially mediated by regulation of the miR-15 family. Int J Biochem Cell Biol. 2013;45(12):2724-2735.
[31] MA X, YAO H, YANG Y, et al. miR-195 suppresses abdominal aortic aneurysm through the TNF-α/NF-κB and VEGF/PI3K/Akt pathway. Int J Mol Med. 2018;41(4):2350-2358.
[32] ZHU L, ZHONG Q, YANG T, et al. Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p. Aging (Albany NY). 2019;11(24): 12236-12245.
[33] WANG QM, LIAN GY, SONG Y, et al. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335.
[34] LIU D, ZHU Y, PANG J, et al. Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195. J Cell Biochem. 2018;119(2):1368-1380.